Kapitalo Investimentos Ltda Sells 1,638 Shares of Globe Life Inc. (NYSE:GL)

Kapitalo Investimentos Ltda trimmed its position in Globe Life Inc. (NYSE:GL) by 73.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 584 shares of the company’s stock after selling 1,638 shares during the quarter. Kapitalo Investimentos Ltda’s holdings in Globe Life were worth $71,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in GL. Private Trust Co. NA lifted its stake in shares of Globe Life by 270.0% in the 4th quarter. Private Trust Co. NA now owns 222 shares of the company’s stock valued at $27,000 after purchasing an additional 162 shares during the period. Private Wealth Management Group LLC acquired a new position in Globe Life in the fourth quarter valued at about $27,000. BKM Wealth Management LLC bought a new position in Globe Life during the fourth quarter worth about $28,000. Lindbrook Capital LLC grew its position in shares of Globe Life by 62.2% during the 4th quarter. Lindbrook Capital LLC now owns 240 shares of the company’s stock worth $29,000 after buying an additional 92 shares during the period. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of Globe Life by 177.0% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 277 shares of the company’s stock valued at $34,000 after acquiring an additional 177 shares during the last quarter. 81.61% of the stock is owned by institutional investors.

Globe Life Trading Up 2.7 %

NYSE GL opened at $82.57 on Friday. Globe Life Inc. has a 52 week low of $38.95 and a 52 week high of $132.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.05 and a current ratio of 0.05. The stock’s 50 day moving average price is $78.49 and its two-hundred day moving average price is $106.29. The stock has a market capitalization of $7.62 billion, a price-to-earnings ratio of 7.89 and a beta of 0.81.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Monday, April 22nd. The company reported $2.78 EPS for the quarter, missing analysts’ consensus estimates of $2.79 by ($0.01). The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.42 billion. Globe Life had a return on equity of 23.01% and a net margin of 18.07%. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.53 EPS. As a group, analysts anticipate that Globe Life Inc. will post 11.72 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 1st. Investors of record on Friday, July 5th will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Friday, July 5th. This represents a $0.96 annualized dividend and a yield of 1.16%. Globe Life’s payout ratio is presently 9.17%.

Analyst Ratings Changes

GL has been the subject of a number of analyst reports. Piper Sandler decreased their price objective on shares of Globe Life from $130.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, April 24th. Keefe, Bruyette & Woods raised shares of Globe Life from a “market perform” rating to an “outperform” rating and decreased their price target for the company from $130.00 to $110.00 in a report on Wednesday, April 24th. Evercore ISI dropped their price objective on Globe Life from $125.00 to $75.00 and set an “in-line” rating on the stock in a research note on Friday, April 12th. Wells Fargo & Company decreased their target price on Globe Life from $132.00 to $108.00 and set an “overweight” rating for the company in a research note on Wednesday, April 24th. Finally, Raymond James reaffirmed a “strong-buy” rating on shares of Globe Life in a research report on Tuesday, May 21st. Five analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $114.33.

Insider Activity at Globe Life

In related news, Director David A. Rodriguez acquired 1,500 shares of the company’s stock in a transaction dated Wednesday, April 24th. The shares were bought at an average price of $79.72 per share, for a total transaction of $119,580.00. Following the purchase, the director now directly owns 4,192 shares in the company, valued at approximately $334,186.24. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, EVP Rebecca E. Zorn sold 2,320 shares of Globe Life stock in a transaction dated Thursday, April 25th. The stock was sold at an average price of $77.30, for a total transaction of $179,336.00. Following the completion of the transaction, the executive vice president now owns 10,220 shares in the company, valued at $790,006. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David A. Rodriguez acquired 1,500 shares of the company’s stock in a transaction on Wednesday, April 24th. The stock was acquired at an average price of $79.72 per share, for a total transaction of $119,580.00. Following the purchase, the director now directly owns 4,192 shares of the company’s stock, valued at $334,186.24. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 6,500 shares of company stock valued at $536,860. Insiders own 1.51% of the company’s stock.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.